FDA Approves First Oral Treatment for Anemia Caused by Chronic Kidney Disease for Adults on Dialysis
The U.S. Food and Drug Administration recently approved Jesduvroq tablets (daprodustat) as the first oral treatment for anemia (decreased number of red blood cells) caused by chronic kidney disease for …
FDA Approves First Oral Treatment for Anemia Caused by Chronic Kidney Disease for Adults on Dialysis Read More